BioNexus Gene Lab Corp. (NASDAQ:BGLC – Get Free Report) saw a large increase in short interest in the month of September. As of September 15th, there was short interest totalling 852,200 shares, an increase of 670.5% from the August 31st total of 110,600 shares. Based on an average daily volume of 369,600 shares, the short-interest ratio is presently 2.3 days. Currently, 7.3% of the shares of the stock are sold short.
BioNexus Gene Lab Price Performance
NASDAQ:BGLC traded up $0.02 on Friday, reaching $0.45. The stock had a trading volume of 41,734 shares, compared to its average volume of 705,169. BioNexus Gene Lab has a 1-year low of $0.31 and a 1-year high of $3.39. The stock has a fifty day moving average price of $0.44 and a 200-day moving average price of $0.53.
BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) last released its quarterly earnings results on Wednesday, August 14th. The company reported $0.01 EPS for the quarter. BioNexus Gene Lab had a negative net margin of 24.01% and a negative return on equity of 23.07%. The business had revenue of $1.98 million for the quarter.
Hedge Funds Weigh In On BioNexus Gene Lab
About BioNexus Gene Lab
BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.
Further Reading
- Five stocks we like better than BioNexus Gene Lab
- What Are Dividend Champions? How to Invest in the Champions
- Can Costco Stock Hit New Highs as Interest Rates Drop?
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- These 3 Stocks Show How to Navigate Declining Consumer Confidence
- Best Aerospace Stocks Investing
- MicroStrategy’s Returns Are 3X Higher Than Bitcoin: Time to Buy?
Receive News & Ratings for BioNexus Gene Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNexus Gene Lab and related companies with MarketBeat.com's FREE daily email newsletter.